<DOC>
	<DOCNO>NCT00165191</DOCNO>
	<brief_summary>The purpose study collect information anti-tumor activity combination doxorubicin , cisplatin , 5-fluorouracil give patient advanced esophageal gastric adenocarcinoma . We also collect information side effect safety combination .</brief_summary>
	<brief_title>Doxorubicin , Cisplatin , 5-Fluorouracil Patients With Advanced Adenocarcinoma Stomach Esophagus</brief_title>
	<detailed_description>- Patients receive cisplatin doxorubicin intravenously every 3 week . In addition cisplatin doxorubicin , patient receive 5-fluorouracil intravenously continuous infusion duration study . In order , patient receive infusion pump carry . Treatment cycle repeat every 21 day maximum 8 cycle . - Prior enrollment study patient receive therapy , routine blood test x-ryas ( include chest x-rays CT scan ) perform check body 's response treatment . Blood test check week chest x-rays CT scan check every 6 week . - Patients progressive disease intolerable side effect remove study . Patients stable disease tumor response continue therapy maximum 8 cycle .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Measurable , locally unresectable metastatic adenocarcinoma stomach , GE junction esophagus No one prior chemotherapy regimen ECOG performance status &lt; equal 2 Life expectancy &gt; 12 week ANC &gt; 1,500/mm3 Hemoglobin &gt; 9.0 gm/dl Platelets &gt; 100,000/mm3 SGOT &lt; 3 x ULN Total bilirubin &lt; 2.0 mg/dl Creatinine &lt; 1.5 mg/dl Prior cisplatin doxorubicin neoadjuvant adjuvant therapy 1 year study entry Clinically apparent central nervous system metastases carcinomatous meningitis Myocardial infarction past 6 month Major surgery past 2 week Uncontrolled serious medical psychiatric illness Pregnant lactate woman Concurrent malignancy site , except limited basal cell carcinoma squamous cell carcinoma skin carcinoma situ cervix History clinical evidence congestive heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>doxorubicin</keyword>
	<keyword>cisplatin</keyword>
	<keyword>5-fluorouracil</keyword>
	<keyword>stomach cancer</keyword>
	<keyword>esophagus cancer</keyword>
</DOC>